AKARI THERAPEUTICS PLC

Profile

Company Names

AKARI THERAPEUTICS PLC
CELSUS THERAPEUTICS PLC.
MORRIA BIOPHARMACEUTICALS PLC

Addresses

401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL 33602

22 BOSTON WHARF ROAD, FL 7, BOSTON, MA 02210

75/76 WIMPOLE STREET, LONDON, X0 W1G 9RT

THE GRIDIRON BUILDING, ONE PANCRAS SQUAR, C/O PEARL COHEN ZEDEK LATZER BARATZ UK L, LONDON, X0 N1C 4AG

53 DAVIES STREET, LONDON, X0 W1K 5JH

Phone Numbers

(929) 274-7510
(646) 350-0702
+44 20 8004 0270
+44-203-318-3004
+44-207-152-6341

 

Entity Type:

OTHER

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

UNITED KINGDOM

Total Amount Raised:

$141,212,728.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2026-05-20 
$1,833,333.00 
$5,500,000.00 
$3,666,667.00 
 
11
2025-10-16 
$6,250,000.00 
$6,250,000.00 
$0.00 
 
10
2023-12-27 
$2,000,001.00 
$2,000,001.00 
$0.00 
Equity 
9
2023-10-04 
$1,971,001.00 
$1,971,001.00 
$0.00 
Equity 
8
2022-09-14 
$12,835,000.00 
$12,835,000.00 
$0.00 
 
7
2021-07-07 
$12,318,688.00 
$12,318,688.00 
$0.00 
Equity 
6
2020-02-13 
$9,554,528.00 
$9,554,528.00 
$0.00 
Equity 
5
2019-06-28 
$4,499,945.00 
$4,499,945.00 
$0.00 
 
4
2015-09-18 
$75,000,000.00 
$75,000,000.00 
$0.00 
Equity 
3
2013-09-24 
$12,516,232.00 
$12,516,232.00 
$0.00 
Equity 
2
2013-01-18 
$931,000.00 
$10,000,000.00 
$9,069,000.00 
Equity 
1
2012-11-30 
$1,503,000.00 
$1,503,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROB 
 
BAZEMORE 
DIRECTOR
MELISSA 
 
BRADFORD-KLUG 
EXECUTIVE OFFICER
DAVID 
 
BYRNE 
DIRECTOR
ROBERT 
 
DOMAN 
DIRECTOR
AMOS 
 
EIRAN 
DIRECTOR
DOV 
 
ELEFANT 
EXECUTIVE OFFICER, DIRECTOR
KAMEEL 
 
FARAG 
EXECUTIVE OFFICER
PETER 
 
FELDSCHREIBER 
DIRECTOR
ABIZER 
 
GASLIGHTWALA 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
GRISSINGER 
DIRECTOR
WA-EL 
 
HASHAD 
DIRECTOR
TORSTEN 
 
HOMBECK 
EXECUTIVE OFFICER
RACHELLE 
 
JACQUES 
EXECUTIVE OFFICER, DIRECTOR
JIM 
 
NEAL 
DIRECTOR
MILES 
 
NUNN 
EXECUTIVE OFFICER
SANDIP 
 
PATEL 
DIRECTOR
FREDRIC 
 
PRICE 
DIRECTOR
DR. RAY 
 
PRUDO 
DIRECTOR
RAY 
 
PRUDO 
DIRECTOR, EXECUTIVE OFFICER
GILEAD 
 
RADAY 
DIRECTOR
CLIVE 
 
RICHARDSON 
EXECUTIVE OFFICER, DIRECTOR
GUR 
 
ROSHWALB 
EXECUTIVE OFFICER, DIRECTOR
ALLAN 
 
SHAW 
DIRECTOR
STUART 
 
UNGAR 
DIRECTOR
DONALD 
 
WILLIAMS 
DIRECTOR
SAUL 
 
YEDGAR 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-05-20 
D
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-10-16 
D
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-27 
D
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-10-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-09-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-07-07 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-02-13 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-06-28 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-09-18 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-09-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-01-18 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2012-11-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2012-11-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
NONE
NONE
LADENBURG THALMANN + CO. INC.
NONE
NONE
PAULSON INVESTMENT COMPANY LLC
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
NONE
NONE
MTS SECURITIES, LLC
NONE
NONE
CITIGROUP GLOBAL MARKETS INC.
NONE
NONE
MTS SECURITIES, LLC
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
GARDEN STATE SECURITIES, INC.